European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
G Raverot, P Burman, A McCormack… - European journal of …, 2018 - academic.oup.com
Background Pituitary tumours are common and easily treated by surgery or medical
treatment in most cases. However, a small subset of pituitary tumours does not respond to …
treatment in most cases. However, a small subset of pituitary tumours does not respond to …
Treatment strategies for dopamine agonist-resistant and aggressive prolactinomas: a comprehensive analysis of the literature
Despite most of the prolactinomas can be treated with endocrine therapy and/or surgery, a
significant percentage of these tumors can be resistant to endocrine treatments and/or recur …
significant percentage of these tumors can be resistant to endocrine treatments and/or recur …
Effect of everolimus in treatment of aggressive prolactin-secreting pituitary adenomas
D Zhang, JS Way, X Zhang, M Sergey… - The Journal of …, 2019 - academic.oup.com
Context Aggressive prolactin (PRL)-secreting pituitary adenomas that are resistant to
conventional therapy with dopamine agonists, surgery, and radiation pose a therapeutic …
conventional therapy with dopamine agonists, surgery, and radiation pose a therapeutic …
Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review
MH Almalki, NN Aljoaib, MJ Alotaibi, BS Aldabas… - Hormones, 2017 - Springer
Abstract Pituitary tumors represent 10–15% of all intracranial tumors; of these, prolactinomas
account for 40–50% of cases. Prolactinomas usually respond well to dopamine agonists …
account for 40–50% of cases. Prolactinomas usually respond well to dopamine agonists …
[HTML][HTML] Aggressive pituitary tumors and pituitary carcinomas
SMC De Sousa, AI McCormack - Endotext [Internet], 2022 - ncbi.nlm.nih.gov
Aggressive pituitary tumors (APT) refer to pituitary adenomas exhibiting radiological
invasiveness and an unusually rapid tumor growth rate, or clinically relevant tumor growth …
invasiveness and an unusually rapid tumor growth rate, or clinically relevant tumor growth …
[HTML][HTML] Current and Perspective Approaches to the Treatment of Prolactinomas
T Tykhonova, N Barabash, O Kanishcheva - Acta Medica Lituanica, 2023 - ncbi.nlm.nih.gov
Background Along with the presence of the 2011 Endocrine Society Clinical Practice
Guidelines and numerous large-scale studies on the treatment of hyperprolactinemia of …
Guidelines and numerous large-scale studies on the treatment of hyperprolactinemia of …
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor
Dopamine agonists (DAs, especially cabergoline) are recommended as first-line treatment
in patients with prolactin-secreting pituitary adenomas, to reduce hormone secretion and …
in patients with prolactin-secreting pituitary adenomas, to reduce hormone secretion and …
Clinical, Immunological And Molecular-Genetic Characteristic Of Aggressive Pituitary Adenomas
KZ Yusufovna, AO TalAtovna - The American Journal of Medical …, 2021 - inlibrary.uz
Pituitary adenomas (PA) are monoclonal tumors arising from the cells of the
adenohypophysis and represent approximately 10-15% of all intracranial tumors and 90% of …
adenohypophysis and represent approximately 10-15% of all intracranial tumors and 90% of …
The role of the TGFβ signaling pathway in clinically non-functioning pituitary adenoma and the potential role of inhibitors of this pathway as a new target in pituitary …
MC Saan - 2022 - edoc.ub.uni-muenchen.de
The parenchyme of the anterior pituitary gland consists of various distinct endocrine cells
which second to the hypothalamic-releasing hormones regulates all other endocrine organs …
which second to the hypothalamic-releasing hormones regulates all other endocrine organs …
[HTML][HTML] Current and Perspective Approaches to the Treatment of Prolactinomas
T Tykhonova, N Barabash, O Kanishcheva - zurnalai.vu.lt
Background: Along with the presence of the 2011 Endocrine Society Clinical Practice
Guidelines and numerous large-scale studies on the treatment of hyperprolactinemia of …
Guidelines and numerous large-scale studies on the treatment of hyperprolactinemia of …